Distress and Care Utilization in Patients with Myeloproliferative Neoplasms
Despite consensus recommendations, most patients with distress ≥4 were not evaluated by SS. Future work should identify ways to better use patient-reported outcomes to promote early intervention.
Authors
- Thomas G. Knight
- Aleksander L. Chojecki (ORCID: https://orcid.org/0000-0003-2841-8321)
- Rushil Virendra Patel (ORCID: https://orcid.org/0000-0002-2856-6271)
- Declan Walsh (ORCID: https://orcid.org/0000-0002-9310-1729)
- Ruben A. Mesa (ORCID: https://orcid.org/0000-0001-5880-7972)
- Patrick Meadors (ORCID: https://orcid.org/0000-0002-1047-8636)
- Michael R. Grunwald (ORCID: https://orcid.org/0000-0001-5407-9875)
- Brittany Knick Ragon (ORCID: https://orcid.org/0000-0002-2460-0698)
- Srinivasa Reddy Sanikommu (ORCID: https://orcid.org/0000-0002-9681-0483)
- Danielle Boselli (ORCID: https://orcid.org/0000-0003-2319-3573)
- James T. Symanowski
- Nilay Shah (ORCID: https://orcid.org/0000-0003-3299-5308)
- Stephanie Begley
- Jing Ai (ORCID: https://orcid.org/0000-0001-6496-7059)
- Rupali Bose
Institutions
- Atrium Health Wake Forest Baptist (US)
- Levine Cancer Institute (US)
- Wake Forest Baptist Comprehensive Cancer Center
Publication Details
- Journal
- Acta Haematologica
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1159/000544162
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00